MGNet: Investigating the Characteristics of Natural Killer Cells in Patients with Autoantibody-Mediated Autoimmune Diseases
24 de abr. de 2024 ·
1m 42s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in The Journal of Immunology on March 1, 2024, titled "A Noncanonical...
mostra más
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in The Journal of Immunology on March 1, 2024, titled "A Noncanonical CD56dimCD16dim/− NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases."
Read the paper here: https://journals.aai.org/jimmunol/article-abstract/212/5/785/266624/A-Noncanonical-CD56dimCD16dim-NK-Cell-Subset?redirectedFrom=fulltext
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
mostra menos
Read the paper here: https://journals.aai.org/jimmunol/article-abstract/212/5/785/266624/A-Noncanonical-CD56dimCD16dim-NK-Cell-Subset?redirectedFrom=fulltext
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
